Understanding Late-Stage Clinical Trial Failure in Multiple Sclerosis: Insights from ClinicalTrials.gov
- DOI
- 10.1159/000551962
- Published
- 2026-04-27
- Container
- Neuroepidemiology
- Publisher
- S. Karger AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1159/000551962,
title = {Understanding Late-Stage Clinical Trial Failure in Multiple Sclerosis: Insights from ClinicalTrials.gov},
author = {Alejandro Rivero-de-Aguilar and Mónica Pérez-Ríos and Joseph S. Ross and Marta Mascareñas-García and Alberto Ruano-Raviña and Leonor Varela-Lema},
year = {2026},
journal = {Neuroepidemiology},
doi = {10.1159/000551962},
url = {https://doi.org/10.1159/000551962}
}RIS
TY - JOUR TI - Understanding Late-Stage Clinical Trial Failure in Multiple Sclerosis: Insights from ClinicalTrials.gov AU - Alejandro Rivero-de-Aguilar AU - Mónica Pérez-Ríos AU - Joseph S. Ross AU - Marta Mascareñas-García AU - Alberto Ruano-Raviña AU - Leonor Varela-Lema PY - 2026 JO - Neuroepidemiology DO - 10.1159/000551962 UR - https://doi.org/10.1159/000551962 ER -
APA
Rivero-de-Aguilar, A., Pérez-Ríos, M., Ross, J. S., Mascareñas-García, M., Ruano-Raviña, A., & Varela-Lema, L. (2026). Understanding Late-Stage Clinical Trial Failure in Multiple Sclerosis: Insights from ClinicalTrials.gov. Neuroepidemiology. https://doi.org/10.1159/000551962
Source records
- crossref · retrieved 2026-09-27T11:45:29.560Z